Beranda › Adenokarsinoma Esofagus
Uji klinis Adenokarsinoma Esofagus yang merekrut di AS
47 studi untuk Adenokarsinoma Esofagus merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY18 studi
- Boston, MA13 studi
- Houston, TX12 studi
- Nashville, TN11 studi
- Arlington, VA11 studi
- Durham, NC10 studi
- Los Angeles, CA9 studi
- Baldwin Park, CA9 studi
- St. Louis, MO9 studi
- Queens, NY9 studi
- Jacksonville, FL9 studi
- Rochester, MN9 studi
- Pittsburgh, PA8 studi
- Chicago, IL8 studi
- Philadelphia, PA8 studi
- Dallas, TX8 studi
- Orange, CA7 studi
- Seattle, WA7 studi
- Ann Arbor, MI7 studi
- Indianapolis, IN6 studi
- Evanston, IL6 studi
- Washington, DC6 studi
- Minneapolis, MN6 studi
- Portland, OR6 studi
- Cleveland, OH6 studi
- Aurora, CO6 studi
- New Haven, CT5 studi
- Sioux Falls, SD5 studi
- Greenburgh, NY5 studi
- Charleston, SC5 studi
- Rochester, NY5 studi
- Kansas City, MO5 studi
- San Antonio, TX5 studi
- Denver, CO5 studi
- Tampa, FL4 studi
- Cedar Rapids, IA4 studi
- Newport Beach, CA4 studi
- Orlando, FL4 studi
- Santa Monica, CA4 studi
- Camden, NJ4 studi
Berdasarkan negara bagian
- Alaska3 studi
- Arizona10 studi
- Arkansas4 studi
- California22 studi
- Colorado11 studi
- Connecticut7 studi
- Delaware3 studi
- Distrik Columbia4 studi
- Florida15 studi
- Georgia5 studi
- Illinois11 studi
- Indiana6 studi
- Iowa5 studi
- Kansas5 studi
- Louisiana3 studi
- Maryland6 studi
- Massachusetts13 studi
- Michigan9 studi
- Minnesota14 studi
- Missouri11 studi
- Nebraska4 studi
- Nevada5 studi
- New Jersey9 studi
- New York20 studi
- North Carolina12 studi
- Ohio12 studi
- Oklahoma4 studi
- Oregon6 studi
- Pennsylvania15 studi
- South Carolina6 studi
- South Dakota5 studi
- Tennessee13 studi
- Texas19 studi
- Utah5 studi
- Virginia13 studi
- Washington9 studi
- Wisconsin7 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05677490A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07090499Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06324357A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07221149Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07603375Lucid Registry Study
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05965999Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07392892A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07277413Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06005493Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07546812Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
Menerima pesertaSukarelawan sehat diterima
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06687603A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07818018Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06732388Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Menerima peserta
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05753748A Study of KK2269 in Adult Participants With Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06266299Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07431281Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07282912A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07544589Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07222657A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07182149Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT04221893Obeticholic Acid for Prevention in Barrett's Esophagus
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT04939051A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT06330064A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06657144Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.